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Recognition motif and mechanism 
of ripening inhibitory peptides in 
plant hormone receptor ETR1
Dalibor Milić  1,4, Markus Dick2,5, Daniel Mulnaes2, Christopher Pfleger2, Anna Kinnen1, 
Holger Gohlke 2,3 & Georg Groth1
Synthetic peptides derived from ethylene-insensitive protein 2 (EIN2), a central regulator of ethylene 
signalling, were recently shown to delay fruit ripening by interrupting protein–protein interactions in 
the ethylene signalling pathway. Here, we show that the inhibitory peptide NOP-1 binds to the GAF 
domain of ETR1 – the prototype of the plant ethylene receptor family. Site-directed mutagenesis and 
computational studies reveal the peptide interaction site and a plausible molecular mechanism for the 
ripening inhibition.
Ripening of climacteric fruits, such as apples and tomatoes, is induced by the plant hormone ethylene. Such 
fruits and vegetables are usually harvested, transported, and stored in a green, unripe state, and full ripening is 
then induced by ethylene exposure at the final destination shortly before delivery. In order to avoid fruit damage 
and spoilage due to overripening, strategies have been developed to control ripening and minimize postharvest 
losses1 by interfering with ethylene biosynthesis or signalling. Much of the current knowledge on signal per-
ception and transduction of the plant hormone has been established by physiological, biochemical and genetic 
studies in the model plant Arabidopsis thaliana. Overall, more than a dozen genes have been implicated in the 
ethylene-signaling pathway, and their multi-stage interconnecting network has been tentatively determined 
using a combination of genetic and molecular approaches. In Arabidopsis, the ethylene signal is perceived by 
a family of five receptor proteins, which form homo- and heterodimers at the membrane of endoplasmic retic-
ulum (ER) and function as negative regulators of the ethylene response2–7. The receptors are modular (Fig. 1a), 
organized similar to bacterial sensor histidine kinases and contain N-terminal transmembrane sensor domains 
(TM) followed by a cytosolic GAF domain (GAF), a dimerization histidine-phosphotransfer (DHp) and a cat-
alytic ATP-binding (CA) domain forming the catalytic core, and a C-terminal response regulator domain (RD; 
not present in all members of the ethylene receptor family)8,9. Although the exact output of the receptors is still 
obscure, genetic studies demonstrate that in the absence of ethylene, receptors activate the Raf-like protein 
kinase CONSTITUTIVE TRIPLE RESPONSE 1 (CTR1), a negative regulator of the pathway10. Although CTR1 
lacks any predicted transmembrane domains, it also resides at the ER membrane due to its physical interac-
tion with the receptors11. Interaction with the receptors is considered critical for the induction of CTR1 kinase 
activity. Downstream of the receptors and the ER associated CTR1 kinase the membrane protein ETHYLENE 
INSENSITIVE 2 (EIN2) implements a positive regulatory role on ethylene signaling. The integral membrane pro-
tein was identified as the most crucial step in ethylene signaling since ein2 is the only gene whose loss-of-function 
mutation confers complete ethylene insensitivity to the plant12. Recently, we identified inhibitory oligopeptides 
that delay ripening of tomatoes (Solanum lycopersicum) when applied onto the surface of an unripe fruit before 
or after its harvesting13–15. Their amino acid sequences are based on a highly conserved nuclear localization signal 
(NLS) found at the C-terminus of EIN216. Molecular and genetic studies revealed that the C-terminal cytoplasmic 
part of EIN2 (EIN2-CEND) gets cleaved in the presence of ethylene by a so far unknown mechanism and has a 
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crucial role in regulating expression of ethylene response genes17–21. Recent work in our laboratory showed that 
the synthetic inhibitory peptides derived from the NLS motif at the EIN2 C-terminus bind directly to ethylene 
receptors14,15 and disrupt their interactions with EIN2-CEND13,14.
In this report, we demonstrate that the inhibitory peptides bind to the GAF domain of ethylene receptor 1 
(ETR1). Furthermore, the results of our experimental and computational biophysical studies not only indicate the 
peptide interaction site but also suggest a probable molecular mechanism of the ripening inhibition.
Results and Discussion
To understand the structural basis of interactions between ethylene receptors and inhibitory peptides, we het-
erologously expressed and purified C-terminally truncated constructs of ETR1 from the plant model organism 
A. thaliana (AtETR1), which were successively lacking protein domain modules starting from the C-terminus 
(Fig. 1a and Supplementary Fig. S1). Our goal was to identify AtETR1 domain(s) crucial for the interaction 
with the archetypal inhibitory octapeptide NOP-1 (LKRYKRRL-NH2)13–15, the sequence of which matches 
exactly the NLS sequence found in EIN2 of most plant species14, including A. thaliana and tomato. Therefore, 
we used microscale thermophoresis to characterize binding of NOP-1 to the fluorescently labelled full-length 
AtETR1 and each of its four C-terminally truncated constructs (Fig. 1b,c and Supplementary Fig. S2). Out of 
these, AtETR11–157, containing the transmembrane (TM) domain only, showed no binding to the inhibitory 
peptide. All other C-terminally truncated constructs bound NOP-1 with binding affinities very similar to 
those of the full-length protein (dissociation constant Kd = 88 ± 41 nM; Fig. 1c). To further explore the role of 
the histidine kinase (DHp and CA) or receiver domains (RD) in binding of NOP-1, we prepared AtETR1306–738 
containing only these domains. To our surprise, we observed no binding of NOP-1 to AtETR1306–738 (Fig. 1b), 
thus ruling out our initial hypothesis that the NOP-1 binding site corresponds to a canonical phosphoryla-
tion site in the ETR1 histidine kinase or receiver domain13. Taken together, these results pinpointed the GAF 
domain as the ETR1 structural unit that interacts with NOP-1. Moreover, the three extended peptides NIP-1 
(AFPKGKENLASVLKRYKRRL-NH2)13, N30P (GRTGTAAGDVAFPKGKENLASVLKRYKRRL-NH2), and 
N41P (KDVEMAISSRKGRTGTAAGDVAFPKGKENLASVLKRYKRRL-NH2) – all of which were derived 
from the AtEIN2 sequence and contain the NLS motif with additional 12, 22, or 33 upstream amino acid res-
idues, respectively – also showed binding to AtETR11–307 (Fig. 1c and Supplementary Fig. S2). Their binding 
affinities improved with increasing peptide length, highlighting the importance of the NLS-core motif in this 
Figure 1. Identification of the AtETR1 domain interacting with inhibitory octapeptide NOP-1. (a) Modular 
organization of the AtETR1 structure. The receptor forms a covalent dimer via two disulfide bridges at the 
N-terminus. The ethylene binding site (Cu+ ion) is situated at the interface of two α-helical transmembrane 
(TM) domains immersed in a membrane of the endoplasmic reticulum (ER). The highly flexible cytoplasmic 
part of AtETR1 is composed of four domains: a GAF, a dimerization histidine-phosphotransfer (DHp), a 
catalytic ATP-binding (CA), and a receiver (RD) domain. DHp and CA domains are parts of a histidine 
kinase functional unit. (b) Binding of NOP-1 to the truncated AtETR1 constructs studied by microscale 
thermophoresis (MST). ∆Fnorm is a relative normalized fluorescence measured for a fluorescently labelled 
protein at constant concentration (25 nM) in the presence of NOP-1 at different concentrations, c(NOP-1). 
AtETR11–307 (TM–GAF) still binds NOP-1, while AtETR11–157 (TM) and AtETR1306–738 (DHp–CA–RD) show no 
binding. Mean values and standard deviations of ∆Fnorm are plotted. (c) Dissociation constants (Kd) determined 
in MST binding experiments with the truncated AtETR1 constructs. All corresponding binding curves are 
presented in Supplementary Fig. S2.
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interaction along with the positive correlation of sequence length on folding and/or stability of the biologicals 
(Supplementary Fig. S3).
Previous in vivo studies by various labs7,22,23 have demonstrated a crucial role of the GAF domain for noncova-
lent homo- and hetero-oligomerization of ethylene receptors. Even before these discoveries, several researchers 
proposed that non-covalent interactions between the receptors and formation of higher-order oligomers might 
have functional implications in ethylene signalling and could explain the high sensitivity and broad concentration 
range of ethylene response24–27.
To further understand the nature of peptide–GAF domain interactions, we first focused on predicting possible 
common structural motifs of peptides NOP-1, NIP-1, N30P, and N41P. We used 50 μs long molecular dynamics 
(MD) simulations, with three independent replicates for each system, in implicit solvent to perform ab initio fold-
ing simulations, motivated by recent successful studies28,29. In neither case did we see tertiary structure formation, 
and, except for specific regions (amino acids 7–9, 11–15 that tend to form α-helices), the major secondary struc-
tural elements were random coils (Supplementary Fig. S3a); these predictions were confirmed by CD spectros-
copy (Supplementary Fig. S3b,c). Hence, it was not possible to identify a common structural motif. Nevertheless, 
such a result is not completely unexpected, considering the short length and high number of positive charges of 
the peptides, and the fact that the peptide sequences are part of the C-terminal domain of AtEIN2, which is pre-
dicted to be mainly disordered (60% disordered regions according to DISOPRED30).
As no experimental structure of the ETR1 GAF domain has been reported so far, we used our in-house soft-
ware package TopModel31 to build a structural model based on available templates (Supplementary Fig. S4 and 
Supplementary Table S1) applying the sequence of AtETR1118–305 as the target (PDB ID and chain identifier 
of the templates given, with sequence identity indicated in parentheses: 3P01_A (18%), 3TRC_A (15%), 3CI6_A 
(13%), 3W2Z_A (12%), and 1YKD_B (15%)). A structural alignment between the GAF domain model and the 
templates used is shown in Supplementary Fig. S5. The final model built by TopModel (Fig. 2a) was assessed 
with our in-house model quality assessment program TopScore (D. Mulnaes, H. Gohlke, unpublished results; 
see Materials and Methods section for details) to be 71% correct, with the majority of inaccuracies being located 
in the flexible loop regions (residues in AtETR1 228–247 and 257–272: 47% and 52% inaccuracies, respectively).
Previous findings suggest that ethylene receptors form a dimer in their simplest functional state that is also 
mediated by their GAF domains32. We therefore built a dimer model of the AtETR1 GAF domain using our 
in-house protein–protein docking software TopDock (D. Mulnaes, H. Gohlke, unpublished results). TopDock 
predicts protein–protein contacts based on a structure-based homology search that is independent of sequence. 
TopDock identified five different homologous interfaces (PDB ID and chain identifiers given: 3G6O_AB, 
3IBJ_AB, 3K2N_AB, 3P01_AB, and 3TRC_AB) all of which indicate that the dimer interface consists of the N- 
and C-terminal helices of the GAF domain (Supplementary Fig. S6). TopDock-predicted residue–residue con-
tacts from each homologous interface were used for restrained docking of the GAF domains with HADDOCK33. 
The docking solutions were pooled and clustered by TopDock, and ranked according to HADDOCK energy, 
cluster size, distance to cluster centroid, and fulfilment of predicted contacts to select a docking solution (Fig. 2a). 
Each monomeric subunit of our final model contains a central, antiparallel, seven-fold β-sheet, flanked by one 
short α-helix (amino acids 213–220) and three, parallel-oriented α-helices that cover the N- and C-terminal 
regions (amino acids 118–173 and 290–305). Both N-terminal α-helices form the dimeric interface resulting 
in a six-helix bundle in the homodimeric structure (Fig. 2a). MD simulations of the protein of 500 ns length 
in the absence of any peptide ligand revealed overall moderate structural variations within both monomers 
(Supplementary Fig. S7), when the unstructured loop regions (residues 222–290) were omitted.
To identify interaction sites on the GAF dimer to which NOP-1 binds, we performed 15 independent MD 
simulations of 2 µs length each of free NOP-1 diffusion around the dimer, motivated by our own experience31 and 
that of others34,35 in related studies. To prevent any bias, NOP-1 was randomly placed in the simulation box also 
containing the ETR1 GAF dimer and explicit solvent (Fig. 2b). Over the simulation times, the locations of NOP-1 
at the GAF dimer converge to three binding regions (Fig. 2b): (I) in the upper loop region (residues 283–286), (II) 
nearby the central β-sheets (residues 190–205), and (III) at the helices of the dimeric interface (residues 152–170). 
The propensity of hydrogen bond and salt bridge formation between a protein residue and NOP-1, averaged over 
the entire MD simulation data, confirmed preferred NOP-1/GAF dimer interactions with the three sites (Fig. 2c).
To validate the predictions of the interaction sites, we mutated the residues with the highest frequency of 
hydrogen bond formation (region I: E177, E178, E246, D283; region II: E190, E204; region III: E152, E169; Fig. 3a) 
to alanine and probed for NOP-1/GAF dimer interactions in vitro. AtETR11–307 variants II (E190A, E204A) and 
III (E152A, E169A) showed no binding of NOP-1 in the MST experiments (Fig. 3b). In contrast, AtETR11–307 
variant I (E177A, E178A, E246A, D283A) interacted with NOP-1 with a similar affinity (Kd = 128 ± 65 nM) as the 
unmutated AtETR11–307 (Kd = 104 ± 24 nM), but with a smaller change in the relative normalized fluorescence 
(∆Fnorm). This is probably due to an increased net electric charge of the variant I and the related change in its 
hydration sphere, which ultimately influence both temperature-induced fluorescence jump and thermophoresis, 
and yet do not prevent NOP-1 from binding to the fluorescently labelled protein. Altogether, these results elimi-
nate region I as a NOP-1 interaction site, however they do not clarify the roles of regions II and III in the NOP-1 
binding.
To obtain more insights, we performed intrinsic fluorescence quenching experiments. Initially, we mutated 
two tryptophan residues in the AtETR1 GAF domain (W265 and W288) to phenylalanine to reduce background 
noise by natural tryptophan residues. The third tryptophan (W182) is located in the interior of the GAF domain 
and might be important for its structural integrity; hence, we left it unchanged resulting in the AtETR11–307- 
W265F-W288F construct. This variant was used as reference for individually introducing a tryptophan fluores-
cence reporter in close proximity of each predicted binding region (Fig. 3a). We then monitored intrinsic tryp-
tophan fluorescence of four Trp-mutants (plus reference variant) in the presence of NOP-1 and found the largest 
quenching effect in the case of AtETR11–307-M148W-W265F-W288F – a variant with a tryptophan reporter 
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(M148W) located in binding region III (Fig. 3c and Supplementary Fig. S8). When placing the Trp reporter at a 
more distant position (T161W) to the proposed binding motif at site III, no significant quenching was observed, 
emphasizing that the NOP-1 inhibitory peptide binds in close proximity to acidic residues E152 and E169 in 
region III. In addition, the electrostatic potentials mapped onto the molecular surfaces of the GAF dimer and 
NOP-1 show a strong complementarity at site III, which supports a potential binding motif of NOP-1 at this site 
(Fig. 3d).
To probe a potential influence of NOP-1 binding on the structural stability of the GAF dimer, we used an 
ensemble-based perturbation approach37 integrated into a method for analysing biomolecular rigidity and flex-
ibility38. Initially, we clustered snapshots from the 15 MD simulations of free NOP-1 diffusion, in which NOP-1 
binds to binding site III of the GAF domain on chain A (Fig. 4a,b), in order to combine similar configurations of 
bound NOP-1. Comparing the GAF dimer with and without bound NOP-1 for clusters 1–4 (which cover ~60% 
of all snapshots) revealed an increase in structural stability upon NOP-1 binding for about 60% of the residues 
(Fig. 4c). The largest ∆Gi,CNA were found for the loop region (A175–A180) and residues in the neighbouring 
helix (L167–L174) of the NOP-1-binding domain (Fig. 4c,d), with a maximal ∆Gi,CNA = 0.5 kcal mol−1 for residue 
L176. Notably, even residues up to 20 Å away from the binding site III were influenced by NOP-1 binding, with 
E273 being the most distant one located in the other domain (Fig. 4c,d). The affected residues form a narrow 
pathway running across the dimer interface and extending into the other domain. Root mean square fluctuations 
(RMSF), a measure for atomic mobility, averaged over all MD simulations of the GAF dimer with NOP-1, are 
Figure 2. Molecular modelling of NOP-1 interactions with the GAF domain of AtETR1. (a) Model building 
of the GAF domain (dimeric form). Amino acids 118 to 305 of AtETR1 were used as a target sequence to build 
a homology model using TopModel31. The colouring of the monomeric structures represents the residue-wise 
uncertainty of the predicted model computed by TopScore. Next, protein–protein docking guided by positional 
restraints was performed to determine the interface between both monomeric subunits. As is known from 
experimental data (see Fig. 1b), amino acids 118 to 141 do not interact with NOP-1 and are not needed for 
the dimer formation. Thus, only the part of the protein shown in the dashed black box was used for further 
studies. (b) Starting from different initial NOP-1 positions (left, NOP-1 structures are coloured in beige, while 
the GAF domains are labelled in dark and light grey) 15 MD simulations of 2 µs length were performed. The 
cumulative distribution of the peptide after 100 ns (yellow), 500 ns (turquois), and 2000 ns (pink) over the 15 
MD simulations is shown as points (representing the centre of mass of NOP-1) superimposed onto the average 
structure of the GAF dimer. The three main binding sites are highlighted by red arrows and labelled with 
Roman numerals (I to III). (c) The overall percentage of hydrogen bond and salt bridge formation with NOP-1 
is shown for each residue of the GAF domain over the 15 MD simulations; results obtained for either domain 
in the GAF dimer were averaged. All residues chosen for mutation to alanine are labelled. The Roman numerals 
represent the corresponding binding sites as in panel b.
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smaller by up to ~2 Å compared to MD simulations of the GAF dimer alone in regions distant to binding site III 
(residues 201–207 and 267–276; Supplementary Fig. S9); these regions coincide with those of higher structural 
stability identified by the rigidity and flexibility analysis (Fig. 4c,d). Thus, both independent approaches mutually 
corroborate each other. As the GAF dimer is rotationally symmetric, such an influence will also be felt vice versa 
if NOP-1 binds to the other domain. As a consequence, we speculate that due to the increased structural stability 
of the GAF dimer, the transmission of a signal, arising from ethylene binding to the TM domain of AtETR1, to 
domains C-terminal of the GAF domain is hampered (Fig. 4d). The structural stabilization does not contradict 
the observed Trp fluorescence quenching of the M148W mutant upon NOP-1 binding. We believe a positive 
charge of NOP-1 in close vicinity of W148 outweighs the positive effect that packing stabilization might have on 
the fluorescence intensity and results in the overall fluorescence quenching.
In summary, we have shown that the archetypical ripening inhibitory peptide NOP-1 interacts with the GAF 
domain of the plant ethylene receptor AtETR1 at helices of the dimeric interface. As a result, signal transmis-
sion from the TM domain of AtETR1 to the histidine kinase or receiver domains may be hampered, which may 
explain how NOP-1 inhibits ripening. While currently a full understanding of the AtETR1 signal transduction is 
hindered by the lack of a complete atomistic structure, our speculation is supported in that for a related histidine 
kinase39 such signal transmission involved TM helix movements that are predicted in computational models 
to modulate the structural dynamics of the cytoplasmic domains. The predominant predicted binding mode 
involves primarily residues at the C-terminus of NOP-1, which may explain why the extension of NOP-1 at the 
N-terminus resulting in NIP-1, N30P, and N41P did not interfere with binding. Hence, this peptide part may be 
used to further optimize binding, stability, and applicability.
Figure 3. Evaluation of the predicted binding regions in the GAF domain of AtETR1. (a) Model of AtETR1 
GAF domain with the highlighted acidic residues potentially involved in binding of NOP-1 (region I – red, 
region II – green, region III - cyan). Two tryptophans (W265 and W288) mutated to phenylalanine for the 
intrinsic fluorescence quenching experiments are shown in yellow. The remaining tryptophan (W182) and 
the four residues separately exchanged for tryptophan (fluorescence reporter) are highlighted in orange. (b) 
Binding of NOP-1 to the fluorescently labelled AtETR11–307 and its three variants monitored via microscale 
thermophoresis (relative normalized fluorescence, ∆Fnorm). (c) Tryptophan fluorescence quenching of the 
AtETR11–307 Trp-variants by NOP-1. Fluorescence intensity of each Trp-variant in the presence of 10-fold excess 
of NOP-1 is given relative to fluorescence intensity of each protein measured without NOP-1. The complete 
titration data are presented in Supplementary Fig. S8. Mean values and standard deviations of independent 
triplicate measurements are shown in panels (b) and (c). (d) NOP-1 (within the black box) bound to the GAF 
domain at binding site III, taken from the merged clusters Cl 1–4 (Fig. 4). Circles indicate the three potential 
binding sites of the peptide as in panel (a). The colour scale of the electrostatic potentials ranges from −3.0 (red) 
to + 3.0 (blue) kBT/e; the potentials were computed with the Adaptive Poisson-Boltzmann Solver (APBS)36. The 
view of NOP-1 is rotated by 180°, depicting the binding interface with the GAF dimer.
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Figure 4. Influence of NOP-1 binding on the structural stability of the AtETR1 GAF dimer. (a) The 
dendrogram shows the clustering of 954 NOP-1 configurations bound at site III of the GAF dimer model 
(see Fig. 2). Hierarchical clustering was performed using the all-atom RMSD of NOP-1 as distance metric 
and Ward’s minimum variance algorithm. The dendrogram was cut at a distance threshold δ(c1, c2) = 160 Å 
resulting in six clusters (Cl 1–6). δ(c1, c2) is the square-root of the change in total sum of squares resulting from 
the fusion of clusters c1 and c2.40,41 (b) CNA was applied on each cluster separately, and residues with ∆Gi,CNA 
above a threshold of 0.1 kcal mol−1 are depicted as spheres on the GAF dimer of each cluster centroid45. Blue 
colors reflect predicted ∆Gi,CNA values, with darker colors indicating larger values. (c) The histogram shows 
the per-residue ∆Gi,CNA of the merged clusters Cl 1–4. The dashed line at 0.1 kcal mol−1 indicates the threshold 
above which residues are considered perturbed, and pink colors highlight the region where NOP-1 binds. (d) 
Same information as shown in (c) for the merged clusters Cl 1–4 with NOP-1 bound at site III (salmon). The 
yellow arrow indicates how the perturbation upon removal of NOP-1 influences residues in chain B. The grey 
bars indicate connections to the transmembrane (TM) domain and dimerization domain. Due to the increased 
structural stability of the GAF dimer upon NOP-1 binding, we speculate that the transmission of a signal, 
arising from ethylene binding to the TM domain of AtETR1, to domains C-terminal of the GAF domain is 
hampered.
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Materials and Methods
Inhibitory peptides. C-terminally amidated peptides NOP-1 (LKRYKRRL-NH2), NIP-1 (AFPKGKENLASV 
LKRYKRRL-NH2), N30P (GRTGTAAGDVAFPKGKENLASVLKRYKRRL-NH2) and N41P (KDVEMAISSRKGRT 
GTAAGDVAFPKGKENLASVLKRYKRRL-NH2) were purchased from GenScript as lyophilized trifluoacetate 
(TFA) salts with > 98% HPLC purity and stored at −20 °C. After dissolving a white peptide powder in a buffer 
of choice, peptide concentration in the resulting solution was determined spectroscopically from absorbance at 
280 nm and the calculated molar attenuation coefficient (ProtParam)42.
Molecular cloning. All truncated AtETR1 constructs and AtETR11–307 mutants were prepared in pTEV-16b 
vector backbone43, a modified version of pET-16b (Novagen, Darmstadt, Germany) containing the N-terminal 
decahistidine-tag followed by a linker (SSGH) and a tobacco etch virus (TEV) protease cleavage site (ENLYFQG; 
instead of a Factor Xa cleavage site in pET-16b). The new constructs were made by using a two-fragment PCR 
approach44 starting from the expression plasmid pTEV-16b-AtETR1 that contains the full-length Arabidopsis 
thaliana ethylene receptor 1 (AtETR1) cDNA. In short, the mutagenesis PCR primers were designed in either 
PCRdesign or AAscan program45 with a 21-nucleotides overlap for a mutagenesis primer pair. Each fragment 
was amplified in a PCR with Phusion or Q5 high-fidelity DNA polymerase (both from New England BioLabs) 
or purchased from Integrated DNA Technologies as a gBlocks gene fragment. A pair of fragments was combined 
into the target plasmid in Gibson assembly46, as described in our earlier report44. A detailed overview of the 
molecular cloning as well as the sequences of primers and gene fragments are given in Supplementary Tables S2–
S4. The target constructs were verified by sequencing at SEQLAB Sequence Laboratories Göttingen or at the 
Biological-Medical Research Centre (BMFZ) of the Heinrich Heine University Düsseldorf.
Expression and purification of AtETR1, its C-terminally truncated constructs and AtETR11–307 
mutants. For production of AtETR1 and its variants containing the transmembrane domain, we slightly 
modified our previous protocol27. In brief, the chemically competent E. coli C43 (DE3) (Lucigen Corporation) 
cells were transformed with the corresponding pTEV-16b expression plasmid. Transformants were precultured 
overnight in 2YT medium [16 g L−1 peptone, 10 g L−1 yeast extract and 5 g L−1 NaCl] with 100 µg mL−1 ampicillin 
at 30 °C. Typically, 30 mL preculture was diluted in 500 mL 2YT medium containing 100 µg mL−1 ampicillin in a 
1-L baffled flask. Cultures were incubated at 30 °C while shaking at 180 rpm. The cells were grown to an optical 
density at 600 nm (OD600) between 0.8 and 1.0 and induced with 0.5 mM isopropyl β-d-1-thiogalactopyranoside 
(IPTG). After incubation for additional 5 h, cells were spun down at 7,500 g for 15 min at 4 °C, flash-frozen in liq-
uid nitrogen and stored at −20 °C. If not stated otherwise, all further purification steps were done on ice or at 4 °C. 
Cell pellets thawed on ice were resuspended by vortexing in ice-cold lysis buffer 1 [pH 8.0, 140 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 100 g L−1 glycerol, 20 mg L−1 phenylmethylsulfonyl fluoride (PMSF) 
and 10 mg L−1 DNase I (PanReac AppliChem); 5 mL lysis buffer per 1 g cells] and broken with Constants Cell 
Disruption System (Constant Systems) at 2.4 kbar and 5 °C. Cell debris and inclusion bodies were removed by 
centrifugation at 14,000 g for 30 min. The supernatant was centrifuged further at 40,000 g for 30 min, the resulting 
pellet was washed with the lysis buffer and centrifuged again at 34,000 g for 60 min to isolate cell membranes. 
Membrane pellets were used immediately in further purification or flash-frozen in liquid nitrogen and stored at 
−80 °C. To isolate the His-tagged proteins, membranes were resuspended with a paint brush in the solubilization 
buffer [50 mM Tris/HCl, pH 8.0 at 4 °C, 200 mM NaCl, 12 g L−1 fos-choline-16 (n-hexadecyl-phosphocholine; 
Glycon Biochemicals), 20 mg L−1 PMSF; 10 mL per 1 g membranes] and incubated for 1 h at 4 °C while mixing. 
Insoluble part was spun down at 200,000 g for 30 min and the supernatant was loaded to a 5-mL Ni-NTA HisTrap 
FF column (GE Healthcare Life Sciences) equilibrated with buffer A1 [50 mM Tris/HCl, pH 8.0 at 4 °C, 200 mM 
NaCl, 0.15 g L−1 fos-choline-16, 20 mg L−1 PMSF]. The protein-loaded column was washed with 25 mL buffer 
A1, followed by 100 mL buffer ATP1 [buffer A1 with additional 50 mM KCl, 20 mM MgCl2 and 10 mM adeno-
sine triphosphate (ATP)] to remove copurified chaperone DnaK, 50 mL buffer A and, finally, 50 mL wash buffer 
[buffer A1 with 50 mM imidazole]. His-tagged proteins were eluted with 25 mL elution buffer 1 [buffer A1 with 
250 mM imidazole] and concentrated in a 100-kDa-MWCO Amicon Ultra-15 concentrator (EDM Millipore) 
to a final volume 2.5 mL. Buffer was exchanged for storage buffer 1 [50 mM Tris/HCl, pH 8.0 at 20 °C, 300 mM 
NaCl, 0.15 g L−1 fos-choline-16, 50 g L−1 glycerol] on a desalting PD-10 column (GE Healthcare Life Sciences) 
and the sample was centrifuged at 200,000 g for 30 min. Protein concentration in the supernatant was deter-
mined from absorbance measured at 280 nm and a corresponding molar attenuation coefficient computed using 
the ProtParam tool42. Glycerol was added to purified protein samples to final concentration 200 g L−1. The sam-
ples with glycerol were distributed into 50-µL aliquots in 200-µL PCR tubes, flash-frozen in liquid nitrogen and 
stored at −80 °C. Purified proteins were analysed in SDS-PAGE followed by colloidal Coomassie staining47 or 
western blotting to PVDF membrane (Amersham, GE Healthcare Life Sciences) and immunodetection with 
anti-His-HRP monoclonal antibody (Miltenyi Biotech).
Expression and purification of AtETR1306–738. AtETR1306–738 was expressed in chemically competent E. 
coli BL21 (DE3) Gold cells (Stratagene) additionally transformed with pBB540 and pBB542 plasmids48 (a kind 
gift from Bernd Bukau, Heidelberg University), carrying the genes for chaperones GrpE, ClpB, DnaK, DnaJ, 
GroEL and GroES. Typically, 500 mL terrific broth (TB) medium (12 g L−1 tryptone, 24 g L−1 yeast extract, 5 g L−1 
glycerol, 2.31 g L−1 KH2PO4 and 12.54 g L−1 K2HPO4) with 100 µg mL−1 ampicillin, 34 µg mL−1 chloramphenicol 
and 50 µg mL−1 spectinomycin in a 1-L baffled flask was inoculated with 1 mL overnight preculture and incu-
bated at 37 °C while shaking at 160 rpm. The bacteria were grown to OD600 between 1.1 and 1.3, when they were 
cooled down on ice (5 min incubation), induced with 0.4 mM IPTG and further grown for 18 h at 20 °C. Cells 
were spun down (15 min, 7,500 g), flash-frozen in liquid nitrogen and stored at −20 °C. As already observed for 
some other AtETR1 constructs without the transmembrane domain (AtETR1-ΔTM)32, purified AtETR1306–738 
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precipitated at higher protein concentrations (>1 mg mL−1) in our preliminary purification trials. To circumvent 
this, we used 0.15 g L−1 fos-choline-16 in our purification buffers (the same detergent concentration as for the 
other AtETR1 constructs with the transmembrane domain described in this work). If not stated otherwise, all 
purification steps were performed at 4 °C or on ice. The frozen cell pellet was thawed on ice, resuspended in lysis 
buffer 2 [5 mL buffer per 1 g wet cell pellet; 50 mM Tris/HCl, pH 8.5 at 4 °C, 250 mM NaCl, 20 mM imidazole, 
2.5 mM dithiothreitol (DTT), cOmplete EDTA-free protease inhibitor cocktail (Roche) and 10 mg L−1 DNase I] 
and lysed in Constants Cell Disruption System at 2.4 kbar and 5 °C. Insoluble cell debris was separated by cen-
trifugation at 200,000 g for 30 min, the supernatant was filtered through 0.22-µm syringe filter and loaded on a 
5-mL HisTrap HP column (GE Healthcare Life Sciences) equilibrated with buffer A2 (50 mM Tris/HCl, pH 8.5 
at 4 °C, 250 mM NaCl, 2.5 mM DTT, 0.15 g L−1 fos-choline-16, cOmplete EDTA-free protease inhibitor cocktail). 
The column was washed with 50 mL buffer A2, followed by 100 mL buffer ATP2 [50 mM Tris/HCl, pH 8.5 at 4 °C, 
250 mM NaCl, 2.5 mM DTT, 0.15 g L−1 fos-choline-16, 50 mM KCl, 20 mM MgCl2 and 10 mM ATP], 50 mL buffer 
A2 and 75 mL buffer A2 with 100 mM imidazole. Finally, AtETR1306–738 was eluted with 50 mL elution buffer 2 
(buffer A2 with 250 mM imidazole) and analysed in SDS-PAGE. The fractions containing the target protein were 
poured, concentrated (10-kDa-MWCO Amicon Ultra-15 concentrator, EDM Millipore) and imidazole removed 
by buffer exchange on a PD-10 column for storage buffer 2 [50 mM Tris/HCl, pH 8.5 at at 4 °C, 250 mM NaCl, 
0.15 g L−1 fos-choline-16, 50 g L−1 glycerol, 2.5 mM DTT, cOmplete EDTA-free protease inhibitor cocktail]. The 
protein sample was centrifuged at 200,000 g for 30 min to remove potential aggregates. Finally, glycerol concen-
tration in the supernatant was adjusted to 200 g L−1, the sample divided into 50-µL aliquots in 200-µL PCR-tubes, 
flash-frozen in liquid nitrogen and stored at −80 °C.
Circular dichroism spectroscopy. Peptides and purified protein constructs were characterized in circular 
dichroism (CD) spectroscopy. For that, peptides were directly dissolved in degassed ultrapure Milli-Q water 
(Millipore) or degassed and filtered (0.22-µm filter) CD buffer (10 mM KH2PO4/K2HPO4, pH 8.0 at 20 °C) and 
subsequently diluted to 0.10 mg mL−1. Original buffer of protein samples was exchanged for the CD buffer on a 
desalting PD MiniTrap G-25 column (GE Healthcare Life Sciences). Protein and fos-choline-16 concentrations 
were determined by using a Direct Detect infrared spectrometer (EMD Millipore) and the samples diluted to 
final protein concentration 0.10–0.20 mg mL−1. Fos-choline-16 was added to each blank buffer solution to match 
detergent concentration in the final protein samples. CD spectra were recorded at room temperature on a J-715 
spectropolarimeter (JASCO) using a 1-mm-path-length cylindrical quartz cuvette (Hellma). Each spectrum rep-
resents an average of 10 continuous scans (100 nm min−1) with response time 0.25 s and bandwidth 1.0 nm. CD 
spectra of the peptides were analysed using the K2D2 web server49 (Supplementary Fig. S3b,c). Secondary struc-
ture content of the protein constructs was calculated in programs CDSSTR50, CONTIN51 and SELCON352,53 from 
CDPro software package54 using the reference protein set SMP50 (Supplementary Fig. S10 and S11).
Fluorescent labelling. For the microscale thermophoresis binding experiments, the proteins were labelled 
with thiol-reactive Alexa FluorTM 488 C5 maleimide fluorescent dye (ThermoFisher Scientific). For that, buffer 
of a concentrated freshly purified protein sample was exchanged on a desalting PD MiniTrap G-25 column 
resulting in 800 µL protein sample in labelling buffer [50 mM K2HPO4/KH2PO4, 300 mM NaCl and 0.15 g L−1 
fos-choline-16]. 10 mg mL−1 Alexa FluorTM 488 C5 maleimide dimethyl sulfoxide (DMSO) solution was added to 
the protein sample in 3:1 dye:protein molar ratio and incubated in dark for 30 min at 20 °C while mixing slightly. 
Buffer was exchange for the storage buffer 2 (AtETR1306–738) or storage buffer 1 (all other protein constructs) and 
the sample centrifuged for 30 min at 200,000 g and 4 °C. Spectroscopically determined degrees of labelling in the 
supernatants ranged from 140% to 300% for different AtETR1 constructs. After adjusting glycerol concentration 
to 200 g L−1, the labelled protein samples were divided into 20-µL aliquots in 200-µL PCR tubes, flash-frozen in 
liquid nitrogen and stored at −80 °C.
Microscale thermophoresis (MST). Each inhibitory peptide was dissolved in the binding buffer [50 mM 
Tris/HCl, pH 8.0 at 20 °C, 300 mM NaCl, 0.15 g L−1 fos-choline-16] and serially diluted for MST measurements. 
Alexa-FluorTM-488-labelled AtETR1 constructs were diluted with the binding buffer to concentration 50 nM and 
mixed in a 1:1 volume ratio with each member of the peptide dilution series, resulting in 25 nM fluorescently 
labelled protein in the final 20-µL mixture. The protein–peptide mixtures were centrifuged at 14,000 g for 2 min 
before filling-up standard treated Monolith NT.115 MST glass capillaries (NanoTemper Technologies). Binding 
interactions were characterized in Monolith NT.115 Blue/Green (NanoTemper Technology) at 23–25 °C without 
temperature control. Power of the blue LED (excitation wavelength ca 470 nm) was adjusted depending on a 
degree of fluorescent labelling of each particular construct and fluorescence. Fluorescence in each capillary (emis-
sion wavelength 520 nm) was measured for 5 s without heating, then 30 s heating with 80% infrared laser (MST) 
power followed by 5 s without heating and 25 s delay before measurement of the next capillary. All measurements 
were run in at least three independent replicates. Data were evaluated from temperature jump (fluorescence 
signal between 0.5 s and 1.5 s after applying the laser normalized with the fluorescence signal in the last second 
before applying the laser) and fitted with nonlinear regression to the one-binding-site model55–57 in GraphPad 
Prism version 7.00 for Windows (GraphPad Software, La Jolla California USA). As a negative control, a pro-
tein sample was diluted in the denaturation buffer [50 mM Tris/HCl, pH 8.0 at 20 °C, 300 mM NaCl, 0.15 g L−1 
fos-choline-16, 40 g L−1 sodium dodecyl sulfate (SDS) and 40 mM DTT] and the MST measurements were carried 
out as described above.
Model building. The model structure of the GAF domain (amino acid 142 to 305 of AtETR1) was pre-
dicted using our in-house automated structure prediction pipeline TopModel31,58. TopModel is a multi-template 
meta-approach in which 20 different state-of-the-art threaders (see Supplementary Table S1) are used to detect 
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homologous templates. For each template the Topmodel-Score59 to the native structure, a measure of structural 
similarity, is predicted using deep neural networks. These networks use alignment features, PSIPRED60 second-
ary structure agreement, threading scores from individual threaders, model quality predicted by TopScore (D. 
Mulnaes, H. Gohlke, unpublished results; see also below for details), and structural consensus as input. Based on 
the neural network predictions, false positive templates are removed, consensus alignments are calculated, and 
the templates are ranked according to predicted TopModel-Scores. To sample different alignments, TopModel 
makes an ensemble of multiple sequence alignments (MSAs) using all combinations of the top five templates and 
eight different sequence and structure alignment programs (see Supplementary Table S1). These MSAs are used 
to generate 3D models of the GAF domain using Modeller961 and the template structures. Loops without template 
were refined using the DOPE potential62 and secondary structure restraints based on PSIPRED predictions. The 
generated models were ranked with TopScore, and the highest ranked model for each template combination was 
selected for model combination and refinement. The selected models are refined with ModRefiner63 and scored 
with TopScore. Based on TopScore predictions, regions with errors are removed and the remaining regions used 
as templates to construct meta-models. Two iterations of this refinement and model combination is performed, 
after which the best scoring model according to TopScore is selected as the final model of the GAF domain.
The correctness of the model is measured by TopScore as the predicted global and local lDDT score compared 
to the native structure. The lDDT score compares all intra-molecular heavy-atom distances within two structures 
and, thus, is superposition-free. Two models are considered completely different if all distances deviate by more 
than 4 Å, and completely identical if all distances deviate by less than 0.5 Å. Since the native structure is unknown 
in our case, the score is predicted by a deep neural network which uses multiple sources of information as input. 
These include knowledge-based angle, distance and contact potentials, residue stereochemistry, atom clashes, 
model clustering, and agreement between features predicted from the sequence and measured in the model, such 
as secondary structure, solvent accessibility, and residue contacts. The deep neural network was trained on a large 
data-set of 660 protein targets totaling over 133,000 models and over 19·106 residues.
Molecular dynamics (MD) simulations. The model structure of the GAF domain (amino acid 142 to 
305 of AtETR1) and the linear forms (φ = ψ = 180°) of NOP-1, NIP-1, N30P, and N41P with a C-terminal amino 
(NHE)-cap served as input structures for MD simulations. For receptor–peptide interaction studies, NOP-1 was 
randomly placed next to the GAF dimer with a minimum distance of 8 Å using the software package PackMol64; 
fifteen representative systems were generated that way. The solutes were placed in a truncated octahedral box of 
TIP3P65 water leaving a distance of at least 11 Å between the protein and the solvation box boundaries, and Na+ 
and Cl− ions were added to reach a final salt concentration of 0.15 M. MD simulations were performed with the 
ff14SB force field66. Hydrogen mass repartitioning was used, allowing a time step of 4 fs67. Further parameters for 
system preparation, thermalization, and production runs are described in Minges et al.68. In short, each system 
was prepared performing a conjugate gradient minimization, followed by rising the temperature from 0 K to 
300 K (over 100 ps) and adjusting the system density under NPT conditions. Production NVT-MD simulations 
were performed at 300 K utilizing the Berendsen thermostat69, and conformations were saved every 100 ps.
For peptide folding simulations, three independent replicates (initiated by slightly different thermalization 
temperatures) of 50 µs simulation length were performed for each system. All simulations were performed in 
implicit solvent using the ff14SBonlysc force field in combination with mbondi3 radii and the GB-Neck2 model70 
as described by Nguyen et al.28. In short, after minimization and thermalization, MD simulations were performed 
with a time step of 4 fs using hydrogen mass repartitioning67, temperature control at 300 K with a Langevin ther-
mostat71, and a long-range distance cut-off of 999 Å. Conformations were saved every 1 ns.
The trajectories were analysed with respect to secondary structure formation, distribution of NOP-1 around 
the GAF dimer, and RMSF using cpptraj72. The DSSP method of Kabsch and Sander73 was utilized to calculate sec-
ondary structure types of each residue of NOP-1, NIP-1, N30P, and N41P. Values were averaged over all trajecto-
ries. For calculating the distribution of NOP-1 around the GAF dimer along the 15 MD simulations of free NOP-1 
diffusion, the snapshots were superimposed onto the starting structure of the GAF dimer, a cubic grid with bin 
size 3 × 250 Å2 was placed in the simulation box, and the presence of the centre of mass of NOP-1 within a grid 
bin was assessed after 100, 500, and 2000 ns of simulation time over all snapshots. The number of hydrogen bonds 
(and salt bridges) formed between NOP-1 and each residue of the GAF dimer over all trajectories was determined 
using VMD74, where NOP-1 was chosen as donor and the receptor as acceptor molecule. Prior to computing Cα 
atom RMSF, snapshots of either the 15 MD simulations of free NOP-1 diffusion or the three MD simulations of 
the apo GAF dimer were superimposed onto the starting structure of the GAF dimer.
Tryptophan fluorescence. Steady-state intrinsic fluorescence of the freshly prepared AtETR11–307 
Trp-mutants was measured on a LS-55 fluorescence spectrometer (PerkinElmer) using an excitation wavelength 
295 nm. In the last protein purification step, the elution buffer 1 was exchanged for the binding buffer on a desalt-
ing PD MiniTrap G-25 column. To monitor binding of NOP-1 by fluorescence quenching, each protein sample 
was diluted with the same buffer to final concentration 1 µM and titrated with a concentrated stock solution of 
NOP-1 in the binding buffer at room temperature (22 °C) while stirring slowly in a 4-mm Quartz SUPRASIL 
Macro/Semi-micro cell with a small magnet (PerkinElmer). At the same time, intensity of an emission maximum 
at 344 nm was recorded as an average of 5 measurements. Fluorescence readings were corrected for the dilution 
effect. The inner filter effect of NOP-1 was negligible and could be ignored.
Constraint Network Analysis. To detect changes in biomolecular rigidity and flexibility upon NOP-1 
binding, we analysed ensembles of snapshots in the biomolecule’s bound and unbound states in terms of a pertur-
bation approach37. First, an ensemble of network topologies is saved every 2 ns from the 15 × 2 µs of independent, 
unbiased MD simulations of free NOP-1 diffusion around the GAF dimer (see above). From this ensemble of 
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150,000 conformations, those conformations were extracted that have a hydrogen bond between NOP-1 and the 
residues E152 or E169, indicative of NOP-1 binding to site III of the GAF dimer; this yielded 954 snapshots for the 
ground state. The perturbed state is obtained by removing the covalent and non-covalent interactions associated 
with NOP-1 from each network topology of the ground state. In order to further group similar binding modes 
of NOP-1, we clustered NOP-1 conformations based on a pairwise all-atom RMDS according to Ward’s method 
as implemented in SciPy75. This resulted in six clusters (see Fig. 4a). Second, altered biomolecular stability due to 
removal of NOP-1 is quantified in terms of a per-residue decomposition ΔGi,CNA of the perturbation free energy. 
ΔGi,CNA was computed based on rigidity analyses performed with the CNA software package38 on the ensembles 
of network topologies of the ground and perturbed states. Network topologies (containing nodes (atoms) and 
constraints (covalent and non-covalent interactions)) were constructed with the FIRST (Floppy Inclusions and 
Rigid Substructure Topography) software (version 6.2)76 to which CNA is a front and back end. The strength of 
hydrogen bonds (including salt bridges) were assigned by the energy EHB computed by FIRST77. Hydrophobic 
interactions between carbon or sulfur atoms were taken into account if the distance between these atoms was 
less than the sum of their van der Waals radii (C: 1.7 Å, S: 1.8 Å) plus Dcut = 0.25 Å78. Non-covalent interactions 
between NOP-1 and the GAF domain were identified using knowledge-based DrugScore pair potentials79.
When CNA was applied on each cluster 1–6 (see above) separately, the clusters 5 and 6 revealed only minor 
and local altered structural stability of the GAF dimer upon NOP-1 removal (see Fig. 4b) and, thus, were excluded 
from further analyses. Clusters 1–4 were merged for subsequent analyses. This resulted in a final ensemble of 
592 snapshots used as input for CNA. Upon perturbation, the network topologies lose on average 7.5 (=1.3% 
of all) hydrogen bond constraints and 2.2 (=1.6% of all) hydrophobic tether constraints. About 60% of the 
residues in the GAF domain show altered stability characteristic, with 9% of the residues having ΔGi,CNA val-
ues > 0.1 kcal mol−1 upon removal of NOP-1.
Electrostatic surface potential. The electrostatic surface potential for the GAF dimer and NOP-1 was 
calculated using the Adaptive Poisson-Boltzmann Solver (APBS)36. The complex structure of the GAF dimer and 
NOP-1 were first split into their single components. For the APBS calculations, default parameters were used, the 
temperature of the system was set to 300 K, and the concentration of 1:1 counterions to 0.15 M.
Data availability statement. The data generated and analysed during the current study are either included 
in this published article and its Supplementary Information file or available from the corresponding authors on 
reasonable request.
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